Educational Materials for Active Trials

Numerous clinical trials are always open and enrolling patients in the ECOG-ACRIN Cancer Research Group, which focuses its research on adults 18 years of age and older who have or are at risk of developing cancer. This section of the website contains all educational materials that are publicly available to patients and researchers.

To access educational materials for a particular trial, click on the trial ID in the list below. Materials for closed trials (no longer enrolling patients) can be found in the Archived Educational Materials section.

Cancer Type

Trial ID and Target Patient Population
Any Solid Tumor, Lymphoma, or Myeloma, or Cancer Type with No Standard Treatment Available NCI-MATCH / EAY131 – Eligibility Based on Genetic Testing
Brain EAF151 – Recurrent Glioblastoma
Breast EA1131 – Triple-Negative (Including Men)
EA1151 aka TMIST – Breast Cancer Screening
EAI142 – Newly Diagnosed, Advanced
E2112 – Advanced, Hormone Receptor-Positive and Resistant to Aromatase Inhibitors (Including Men)
6694 – Imaging Substudy for Women in the Alliance A011104 Trial
A011401 aka BWEL – Role of Weight Loss in Overweight Women with Early Breast Cancer
Cancer Care Delivery Research EAQ162CD – Assessment of Financial Burden, Colon/Rectal
Gastrointestinal EA2142 – Pancreas or Gastrointestinal Tract, Advanced
EA2161 – Pancreas
EA2165 – Anal
7151 – Detection of Colon Cancer (By Invitation Only)
Genitourinary EA8134 aka InPACT – Penis
EA8143 aka PROSPER RCC – Kidney
EA8153 aka CHAARTED2 – Hormone-sensitive Prostate
EA8171 – Newly-Diagnosed Prostate (Imaging)
Gynecologic EAE161 – Ovarian, Fallopian Tube, or Peritoneum
Head and Neck EA3132 – p53 Mutated  Squamous Cell, Removed by Surgery
EA3163 – Nasal and Paranasal Sinus Squamous Cell Carcinoma
Leukemia EA9152 – T-cell or B-cell Acute Lymphoblastic Leukemia (ALL)
EAI141 – Acute Myeloid Leukemia (AML)
E1910 – Acute Lymphoblastic (ALL)
E2906 – Acute Myeloid (AML) in Adults Aged 60 Years or Older
NHLBI-MDS aka The National MDS Study – Observation of Myelodysplastic Syndromes (MDS)
Lymphoma EA4151 – Mantle Cell
E4412 – Hodgkin
Melanoma EA6134 – Advanced, BRAFV600 Mutated
EA6141 – Advanced
Myeloma E1A11 aka ENDURANCE – Symptomatic
Patient-Centered Outcomes EA9131 – Acute Promyelocytic Leukemia (APL)
and Survivorship EAQ152 aka COMET – Education About Genomic Testing
E1Q11 aka EROS – Reproductive Health Planning
E1Z11 aka AIMSS – Genetic Predictors in Breast Cancer
Thoracic EA5142, an ALCHEMIST treatment trial – Non-Small Cell Lung, Removed by Surgery and Treated with Chemotherapy
EA5152 – Previously Treated Non-Squamous NSCLC
EA5161 – Extensive Stage Small Cell Lung Cancer
EA5162 – Advanced NSCLC with Exon 20 Insertion Mutations in EGFR
E4512, an ALCHEMIST treatment trial – Early, Non-Squamous, Non-Small Cell Lung, Removed by Surgery
4703 aka DECAMP-1 – Detection of Early Lung Cancer in Military Personnel
4704 aka DECAMP-2 – Screening of Military Personnel with Early Stage Lung Cancer or at High Risk of Developing Lung Cancer
6697 – Imaging Substudy for Patients in the RTOG 1106 Trial
Lung-MAP – Squamous Cell Lung
2091
Resources
Group Meetings
Trial Educational Materials
NCI-MATCH / EAY131 for Researchers
Publications
ECOG Performance Status
CIRB
Medidata Rave®
TRIAD™
SOAPP
PrECOG
Related Websites
Document Library